PSCH vs. BBH
PSCH (Invesco S&P SmallCap Health Care ETF) and BBH (VanEck Vectors Biotech ETF) are both Health & Biotech Equities funds - PSCH tracks the S&P SmallCap 600 Health Care Index while BBH tracks the MVIS US Listed Biotech 25 Index. Both are passively managed. Over the past 10 years, PSCH returned 6.81%/yr vs 5.75%/yr for BBH. A 0.69 correlation means they provide meaningful diversification when combined. PSCH charges 0.29%/yr vs 0.35%/yr for BBH.
Performance
PSCH vs. BBH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PSCH achieves a 1.80% return, which is significantly higher than BBH's -1.85% return. Over the past 10 years, PSCH has outperformed BBH with an annualized return of 6.81%, while BBH has yielded a comparatively lower 5.75% annualized return.
PSCH
- 1D
- 1.28%
- 1M
- -0.71%
- YTD
- 1.80%
- 6M
- -1.68%
- 1Y
- 10.18%
- 3Y*
- 0.45%
- 5Y*
- -5.72%
- 10Y*
- 6.81%
BBH
- 1D
- 2.22%
- 1M
- 0.09%
- YTD
- -1.85%
- 6M
- -5.32%
- 1Y
- 23.92%
- 3Y*
- 6.14%
- 5Y*
- 0.31%
- 10Y*
- 5.75%
PSCH vs. BBH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PSCH Invesco S&P SmallCap Health Care ETF | 1.80% | -0.49% | 3.77% | -2.71% | -25.15% | 5.75% | 31.47% | 20.17% | 9.15% | 34.87% |
BBH VanEck Vectors Biotech ETF | -1.85% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
Correlation
The correlation between PSCH and BBH is 0.66, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.66 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.68 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.70 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.68 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2010 | 0.69 |
The correlation between PSCH and BBH has been stable across timeframes, ranging from 0.66 to 0.70 - a consistent structural relationship.
PSCH vs. BBH - Sectors Allocation Comparison
Sectors
PSCH
BBH
Healthcare
Technology
-
Financial Services
-
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
PSCH
BBH
Technology
PSCH
BBH
-
Financial Services
PSCH
BBH
-
Industrials
PSCH
BBH
-
Basic Materials
PSCH
-
BBH
-
Communication Services
PSCH
-
BBH
-
Consumer Cyclical
PSCH
-
BBH
-
Consumer Defensive
PSCH
-
BBH
-
Energy
PSCH
-
BBH
-
Real Estate
PSCH
-
BBH
-
Utilities
PSCH
-
BBH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PSCH vs. BBH — Risk / Return Rank
PSCH
BBH
PSCH vs. BBH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P SmallCap Health Care ETF (PSCH) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PSCH | BBH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.76 | ||
| Sortino ratioReturn per unit of downside risk | -1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.22 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 0.67 | 2.28 | -1.61 |
| Martin ratioReturn relative to average drawdown | 1.84 | 5.81 | -3.97 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PSCH | BBH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.51 | 1.26 | -0.76 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.25 | 0.01 | -0.27 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | 0.26 | +0.03 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | 0.38 | +0.13 |
Drawdowns
PSCH vs. BBH - Drawdown Comparison
The maximum PSCH drawdown since its inception was -46.32%, smaller than the maximum BBH drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for PSCH and BBH.
Loading charts...
Drawdown Indicators
| PSCH | BBH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.32% | -72.70% | +26.38% |
Max Drawdown (1Y)Largest decline over 1 year | -15.36% | -10.55% | -4.81% |
Max Drawdown (3Y)Largest decline over 3 years | -22.98% | -22.74% | -0.24% |
Max Drawdown (5Y)Largest decline over 5 years | -46.32% | -39.86% | -6.46% |
Max Drawdown (10Y)Largest decline over 10 years | -46.32% | -39.86% | -6.46% |
Current DrawdownCurrent decline from peak | -30.59% | -13.81% | -16.78% |
Average DrawdownAverage peak-to-trough decline | -13.46% | -20.75% | +7.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.54% | 4.13% | +1.41% |
Volatility
PSCH vs. BBH - Volatility Comparison
The current volatility for Invesco S&P SmallCap Health Care ETF (PSCH) is 4.19%, while VanEck Vectors Biotech ETF (BBH) has a volatility of 6.06%. This indicates that PSCH experiences smaller price fluctuations and is considered to be less risky than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PSCH | BBH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.19% | 6.06% | -1.87% |
Volatility (6M)Calculated over the trailing 6-month period | 14.06% | 14.28% | -0.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.26% | 19.02% | +1.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.89% | 21.50% | +1.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.63% | 22.17% | +1.46% |
PSCH vs. BBH - Expense Ratio Comparison
PSCH has a 0.29% expense ratio, which is lower than BBH's 0.35% expense ratio.
Dividends
PSCH vs. BBH - Dividend Comparison
PSCH's dividend yield for the trailing twelve months is around 0.01%, less than BBH's 0.51% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
PSCH Invesco S&P SmallCap Health Care ETF | 0.01% | 0.04% | 0.27% | 0.01% | 2.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% |
Frequently Asked Questions
PSCH and BBH have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBH has higher volatility (6.06%) compared to PSCH (4.19%). In terms of maximum drawdown, PSCH dropped -46.32% vs BBH's -72.70%.
On 10-year performance, PSCH leads with 6.81% vs 5.75% for BBH. On fees, PSCH is cheaper at 0.29% per year. On volatility, PSCH has been the lower-risk option at 4.19%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, PSCH has performed better with a 6.81% return vs 5.75%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PSCH is cheaper with a 0.29% expense ratio, compared with 0.35% for BBH.
BBH has the higher dividend yield at 0.51%, compared with 0.01% for PSCH.
PSCH tracks S&P SmallCap 600 Health Care Index, while BBH tracks MVIS US Listed Biotech 25 Index. They also come from different issuers: Invesco and VanEck. Their fees differ too: 0.29% for PSCH and 0.35% for BBH.
BBH currently has the higher Sharpe Ratio (1.26 vs 0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PSCH and BBH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer